Literature DB >> 19073348

Altered nano/micro-order elasticity of pulmonary artery smooth muscle cells of patients with idiopathic pulmonary arterial hypertension.

Kazufumi Nakamura1, Juichiro Shimizu, Noriyuki Kataoka, Katsushi Hashimoto, Tetsuya Ikeda, Hideki Fujio, Keiko Ohta-Ogo, Aiko Ogawa, Aya Miura, Satoshi Mohri, Satoshi Nagase, Hiroshi Morita, Kengo Fukushima Kusano, Hiroshi Date, Hiromi Matsubara, Seiichi Mochizuki, Ken Hashimoto, Fumihiko Kajiya, Tohru Ohe.   

Abstract

BACKGROUND: Idiopathic pulmonary arterial hypertension (IPAH) is a disease characterized by progressively increased resistance of pulmonary arteries. In this study, we evaluated the mechanical property of single pulmonary artery smooth muscles cells (PASMC) from patients with IPAH and tested whether the PASMC showed abnormal response to a vasodilator by use of an atomic force microscope (AFM).
METHODS: PASMC were isolated and cultured from explanted lungs of 7 patients with IPAH (IPAH-PASMC). Normal vascular specimens from 3 patients with bronchogenic carcinoma were used as normal controls (normal PASMC). The nano/micro-order elasticity of five to ten living PASMC in each sample was measured by parabolic force curves of cantilever deflection/indentation obtained by using an AFM. The elasticity measurements were performed under control conditions and under condition of nitric oxide (NO) treatment (190 and 380 nmol/L).
RESULTS: There was no significant difference between nano/micro-order elasticity of normal PASMC and that of IPAH-PASMC under the control conditions. In normal PASMC, NO (190 and 380 nmol/L) significantly reduced (i.e., softened) the nano/micro-order elasticity. However, NO did not reduce elasticity in IPAH-PASMC, indicating higher vasodilator-resistive nano/micro-order rigidity in IPAH-PASMC.
CONCLUSION: Nano/micro-order elasticity change in PASMC in response to vasodilation induced by NO is reduced in patients with IPAH. Copyright 2008 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19073348     DOI: 10.1016/j.ijcard.2008.11.022

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  5 in total

Review 1.  Epoprostenol sodium for treatment of pulmonary arterial hypertension.

Authors:  Yukihiro Saito; Kazufumi Nakamura; Satoshi Akagi; Toshihiro Sarashina; Kentaro Ejiri; Aya Miura; Aiko Ogawa; Hiromi Matsubara; Hiroshi Ito
Journal:  Vasc Health Risk Manag       Date:  2015-05-14

2.  Eicosapentaenoic acid prevents arterial calcification in klotho mutant mice.

Authors:  Kazufumi Nakamura; Daiji Miura; Yukihiro Saito; Kei Yunoki; Yasushi Koyama; Minoru Satoh; Megumi Kondo; Kazuhiro Osawa; Omer F Hatipoglu; Toru Miyoshi; Masashi Yoshida; Hiroshi Morita; Hiroshi Ito
Journal:  PLoS One       Date:  2017-08-03       Impact factor: 3.240

3.  Nuclear connectin novex-3 promotes proliferation of hypoxic foetal cardiomyocytes.

Authors:  Ken Hashimoto; Aya Kodama; Miki Sugino; Tomoko Yobimoto; Takeshi Honda; Akira Hanashima; Yoshihiro Ujihara; Satoshi Mohri
Journal:  Sci Rep       Date:  2018-08-17       Impact factor: 4.379

4.  Crucial role of RAGE in inappropriate increase of smooth muscle cells from patients with pulmonary arterial hypertension.

Authors:  Kazufumi Nakamura; Masakiyo Sakaguchi; Hiromi Matsubara; Satoshi Akagi; Toshihiro Sarashina; Kentaro Ejiri; Kaoru Akazawa; Megumi Kondo; Koji Nakagawa; Masashi Yoshida; Toru Miyoshi; Takeshi Ogo; Takahiro Oto; Shinichi Toyooka; Yuichiro Higashimoto; Kei Fukami; Hiroshi Ito
Journal:  PLoS One       Date:  2018-09-04       Impact factor: 3.240

5.  Pharmacological Alteration of Cellular Mechanical Properties in Pulmonary Arterial Smooth Muscle Cells of Idiopathic Pulmonary Arterial Hypertension.

Authors:  Shinichi Katsuragi; Nao Tatsumi; Mizuki Matsumoto; Jun Narita; Ryo Ishii; Hidehiro Suginobe; Hirofumi Tsuru; Renjie Wang; Shigetoyo Kogaki; Ryosuke Tanaka; Keiichi Ozono; Takaharu Okajima; Hidekazu Ishida
Journal:  Cardiol Res       Date:  2021-07-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.